Key Highlights

  • ClearOne (NASDAQ:CLRO) fell 14.16% to USD 4.85, with the Cortigent Merger awaiting final regulatory approval.
  • EZGO Technologies (NASDAQ:EZGO) fell 31.74% to USD 0.5425 after announcing a 1-for-3 reverse split.
  • Sangrix (NASDAQ:SGRX) fell 13.20% to USD 0.6406, with 128 Blackwell B300 GPUs due the week of November 3, 2026.
  • Fenbo (NASDAQ:FEBO) fell 15.38% to USD 0.66 on Volume of about 1.73K shares.
  • Jiade (NASDAQ:JDZG) fell 25.84% to USD 0.3904, extending a slide that began on October 28, 2026.

ClearOne (NASDAQ:CLRO) (down USD 0.8000, 14.16%): Giving Back a Monday Rally

ClearOne (NASDAQ:CLRO) was down 14.16% to USD 4.85 in regular trading on November 3, 2026, from a Monday close of about USD 5.65 (calculated). No company announcement dated November 2 or November 3, 2026 was identified. With a public float reported near 714,000 shares, modest trading can swing the price widely.

Under an agreement announced July 2, 2026, Cortigent, a Vivani Medical subsidiary, would become a wholly owned Subsidiary of ClearOne. Closing needs final regulatory approval and a financing of USD 10.0 million to USD 15.0 million. Auditors have expressed substantial doubt about going concern, and Nasdaq staff determined on October 8, 2026 to delist the shares, with a hearing request pausing that action.

EZGO Technologies (NASDAQ:EZGO) (down USD 0.2523, 31.74%): The Third Reverse Split in Under a Year

EZGO Technologies (NASDAQ:EZGO) was down 31.74% to USD 0.5425 in regular trading on November 3, 2026, implying a prior close of about USD 0.7948 (calculated). The likely trigger is a company press release dated November 3, 2026 announcing a one-for-three reverse split, effective November 5, 2026, which cuts shares outstanding from 5,305,950 to about 1,768,650.

This follows a one-for-25 split on November 21, 2025 and a one-for-150 split on May 19, 2026. For the six months ended March 31, 2026, the net loss was USD 3,740,252, and cash was USD 811,852 against an operating outflow of USD 6,257,683. A reverse split does not change the underlying business.

Sangrix (NASDAQ:SGRX) (down USD 0.0974, 13.20%): Retreat Before a GPU Delivery

Sangrix (NASDAQ:SGRX) was down 13.20% to USD 0.6406 in regular trading on November 3, 2026, from a Monday close of about USD 0.7380 (calculated). No company announcement dated November 2 or November 3, 2026 was identified, so the drop appears to continue a retreat after the run that followed an October 16, 2026 delivery update.

That release said 16 servers holding 128 Blackwell B300 GPUs were expected in Malaysia during the week of November 3, 2026, subject to the manufacturer's logistics schedule. A summary of filings lists a 1-for-10 reverse split effective November 13, 2026, and noteholders converted Debt at USD 1.63 per share. With roughly 3.6 million shares outstanding before conversions, dilution risk is elevated.

Fenbo (NASDAQ:FEBO) (down USD 0.1200, 15.38%): A Slide on Almost No Volume

Fenbo (NASDAQ:FEBO) was down 15.38% to USD 0.66 in regular trading on November 3, 2026, from about USD 0.78 on Monday (calculated). Volume was only about 1.73K shares, and no announcement dated October 30 to November 3, 2026 was identified. A move this size on so few shares is more consistent with a handful of small orders than with new information.

Its Shenzhen factory makes hair styling products exported to the United States, and a single U.S. customer accounted for about 100% of Revenue in 2023, 2024 and 2025. The 2025 net loss was HKD 8,785,000, narrower than HKD 13,741,000 in 2024. One holder controls about 98.1% of voting power.

Jiade (NASDAQ:JDZG) (down USD 0.1360, 25.84%): A Slide After a Wild Reversal

Jiade (NASDAQ:JDZG) fell 25.84% to USD 0.3904 in regular trading on November 3, 2026, from a Monday close of about USD 0.5264 (calculated), on volume of about 1.11 million shares. No company announcement dated November 2 or November 3, 2026 was identified. On October 28, 2026 the shares opened near USD 6.30 and touched a low near USD 1.17, and no disclosure confirming the cause was found.

Jiade is a China-based adult education company. It completed a 1-for-25 consolidation on March 23, 2026 and priced registered direct offerings of up to USD 12.0 million in May 2026. With the stock under USD 1.00, a Nasdaq minimum bid price notice is possible, though none was identified for 2026.

Where Things Stand

The five stocks fell between 13.20% and 31.74% in regular trading on November 3, 2026, and all trade as penny stocks. Only EZGO Technologies had a likely identified trigger. Reverse splits and dilution run through the group. Watch the EZGO Technologies split on November 5, the Sangrix delivery and split on November 13, the ClearOne approval and Nasdaq hearing, and any filing that explains the Jiade slide. This article is informational only.